Anzeige
Mehr »
Donnerstag, 03.07.2025 - Börsentäglich über 12.000 News
Nach dem Genius Act: Dieses börsennotierte XRP-Unternehmen greift im Token-Finanzmarkt an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
197 Leser
Artikel bewerten:
(1)

Global Healthcare Regulatory Affairs Outsourcing Market Size Worth USD $12.14 Billion By 2028 | CAGR 5.5%(Including COVID-19 Impact Analysis): Zion Market Research

NEW YORK, Feb. 28, 2022 /PRNewswire/ -- As per Zion Market Research study, Healthcare Regulatory Affairs Outsourcing industry amassed returns worth nearly US$ 5.23 billion in 2020 and is set to register profits of approximately US$ 12.14 billion by 2028. Moreover, Healthcare Regulatory Affairs Outsourcing market is slated to register CAGR of almost 5.5% in 2021-2028.

Zion_Market_Research_Logo

Read Market Research Report "Healthcare Regulatory Affairs Outsourcing Market- By Services (Regulatory Writing & Publishing, Clinical Trial Applications & Services Registrations, Regulatory Consulting & Legal Representation, And Regulatory Submissions), By End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, And Food & Beverage Companies), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 - 2028"

Healthcare regulatory affairs outsourcing market over assessment period can be credited to rise in chronic disorders and huge costs related to research activities. In addition to this, surge in new drug approval time and increase in medical device costs will spur market trends. Apparently, tedious documentation and need for saving time & focusing on core operations has forced firms to outsource healthcare regulatory affairs to third parties, thereby expediting growth of healthcare regulatory affairs outsourcing industry. However, data security concerns can create hurdles in growth path of healthcare regulatory affairs outsourcing market.

Clinical Trial Applications & Services Registrations To Dominate Services Segment By 2028:

Surge in expansion of clinical trial applications & services registrations segment over forecast timeline is subject to rise in outsourcing of clinical trial applications & services in both developed & developing countries. Furthermore, these kinds of services have resulted into huge demand from mid-sized firms, pharmaceutical firms, medical equipment manufacturers, food & beverage firms, and biotech firms.

Biotechnology Companies Segment To Contribute Huge Market Share Over 2021-2028:

Growth of biotechnology companies segment over assessment period is owing to substantial demand for healthcare regulatory affairs outsourcing solutions in biotechnology sector. Need for quick new drug approval and avoid tedious process of documentation related to healthcare regulations affairs will accelerate demand for healthcare regulatory affairs outsourcing activities in biotech sector.

Get More Insight before Buying@: https://www.zionmarketresearch.com/inquiry/healthcare-regulatory-affairs-outsourcing-market

Asia Pacific Market To Record Double Digit CAGR Over Forecast Timespan:

Rapid expansion of healthcare regulatory affairs outsourcing market in Asia Pacific over forecast timespan can be attributed to easy access to skilled workforce at reduced wages. In addition to this, rise in number of clinical tests in pharmaceutical firms based in India and China will proliferate regional market size. Moreover, giant pharmaceutical companies are shifting their base in Asian countries, namely, India, Japan, Taiwan, China, Singapore, and Thailand. Moreover, these moves require documentation of healthcare regulatory activities along with product registrations & clinical trials applications and this will create huge demand for outsourcing healthcare regulatory affairs, thereby driving regional market growth.

Report Scope:

Report Attribute

Details

Market size value in 2020

USD 5.23 Billion

Revenue forecast in 2028

USD 12.14 Billion

Growth Rate

CAGR of almost 27.4% 2021-2028

Base Year

2020

Historic Years

2016 - 2020

Forecast Years

2021 - 2028

Segments Covered

By Product Type, By Application, and By End Use

Forecast Units

Value (USD Billion), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2021 to 2028

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Companies Covered

Accell Clinical Research, LLC, Criterium, Inc., Medpace, Inc., Freyr Solutions, Wuxi AppTec, Labcorp Drug Development, PRA Health Sciences, Inc., Promedica International, PARAXEL International Corporation, and Quintiles IMS Holdings, Inc.

Report Coverage

Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization Scope

Avail customized purchase options to meet your exact research needs.

https://www.zionmarketresearch.com/custom/3369

Request Pre and Post COVID-19 Impact Analysis on Businesses: https://www.zionmarketresearch.com/custom/3369?covid19=true

The Global Healthcare Regulatory Affairs Outsourcing Market is segmented as follows:

Healthcare Regulatory Affairs Outsourcing Market: By Services Outlook (2021-2028)

  • Regulatory Writing & Publishing
  • Regulatory Submissions
  • Clinical Trial Applications & Services Registrations
  • Regulatory Consulting & Legal Representation

Healthcare Regulatory Affairs Outsourcing Market: By End-User (2021-2028)

  • Solutions
  • Services

Healthcare Regulatory Affairs Outsourcing Market: By Region Outlook (2021-2028)

North America

  • The U.S.
  • Canada

Europe

  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Get Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/healthcare-regulatory-affairs-outsourcing-market

Our Free Sample Report Includes:

  • 2021 Updated Report Introduction, Overview, and In-depth industry analysis
  • COVID-19 Pandemic Outbreak Impact Analysis Included
  • 125 + Pages Research Report (Inclusion of Updated Research)
  • Provide Chapter-wise guidance on Request
  • 2021 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes Updated List of tables & figures
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
  • Zion Market Research methodology

List of Key Players of Healthcare Regulatory Affairs Outsourcing Market :

  • Accell Clinical Research
  • Criterium Inc.
  • Medpace Inc.
  • Freyr Solutions
  • Wuxi AppTec
  • Labcorp Drug Development
  • PRA Health Sciences Inc.
  • Promedica International
  • PARAXEL International Corporation
  • Quintiles IMS Holdings Inc.
  • Others.

Key questions answered in this report:

  • What are the growth rate forecast and market size for Healthcare Regulatory Affairs Outsourcing Market?
  • What are the key driving factors propelling the Healthcare Regulatory Affairs Outsourcing Market forward?
  • What are the most important companies in the Healthcare Regulatory Affairs Outsourcing Market Industry?
  • What segments does the Healthcare Regulatory Affairs Outsourcing Market cover?
  • How can I receive a free copy of the Healthcare Regulatory Affairs Outsourcing Market sample report and company profiles?

Press Release For Healthcare Regulatory Affairs Outsourcing Market: https://www.zionmarketresearch.com/news/healthcare-regulatory-affairs-outsourcing-market

  • Browse Other Related Research Reports from Zion Market Research
  • Legal Marijuana Market: The global Legal Marijuana Market accrued earnings worth approximately 10.1 (USD Billion) in 2020 and is predicted to gain revenue of about 70.7(USD Billion) by 2028, is set to record a CAGR of nearly 27.1% over the period from 2021 to 2028.
  • Pharmaceutical Intermediates Market: The global Pharmaceutical Intermediates Market accrued earnings worth approximately 28,117 (USD Million) in 2020 and is predicted to gain revenue of about 39,779 (USD Million) by 2028, is set to record a CAGR of nearly 4.1% over the period from 2021 to 2028.
  • CBD Nutraceuticals Market: The global CBD Nutraceuticals Market accrued earnings worth approximately 4.01 (USD Billion) in 2020 and is predicted to gain revenue of about 8.12 (USD Billion) by 2028, is set to record a CAGR of nearly 18.9% over the period from 2021 to 2028.

Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/healthcare-regulatory-affairs-outsourcing-market

Browse through Zion Market Research's coverage of the Global Pharmaceutical Industry

Follow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/

Follow Us on Twitter: https://twitter.com/zion_research's=11

Follow Us on Facebook: https://www.facebook.com/zionmarketresearch/

About Us

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us-after all-if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website
: https://www.zionmarketresearch.com/
Blog - https://zmrblog.com/

Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg

© 2022 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.